相关实验视频

Updated: May 28, 2025

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

改善急性移植与宿主疾病的初始治疗方法

Ansh Krishnachandra Mehta¹, John Koreth¹

¹Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.

American journal of hematology

|February 12, 2025

概括

急性移植对宿主疾病 (aGVHD) 仍然是干细胞移植的重要并发症. 本综述涵盖aGVHD风险因素,发病因子和不断发展的治疗方法,强调需要改进除皮质类固醇之外的前线治疗方法.

科学领域:

血液学血液学血液学
免疫学免疫学免疫学
移植医学移植医学

背景情况:

急性移植对宿主疾病 (aGVHD) 是全源造血干细胞移植后的一种严重并发症.
它来自于向宿主组织的供体免疫反应,主要影响肝脏,皮肤和胃肠道.

研究的目的:

审查aGVHD的风险因素,流行病学和病原性.
讨论aGVHD.风险分层策略的演变.
总结当前的前线治疗方法,并探索未来的治疗方向.

主要方法:

完成的临床试验和相关研究的文献综述.
对历史和当代风险分层系统的分析.
综合了关于aGVHD病原和管理的数据.

主要成果:

虽然由于改善的HLA类型和预防,发病率正在下降,但皮质类固醇仍然是主要治疗方法.
不断变化的风险分层包括基于生物标志物的方法.
对于增强的前线aGVHD疗法存在着持续的未满足的需求.

结论:

尽管有进展,优化aGVHD的前线治疗至关重要.
未来的战略可能涉及新的生物标志物和向疗法.
持续的研究对于改善移植接收者的结果至关重要.

关键词:

骨髓/干细胞移植骨髓/干细胞移植-移植对宿主病的临床护理-移植对宿主病.骨髓/干细胞移植-急性移植与宿主疾病中的新疗法.

更多相关视频

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice

Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice

Published on: February 11, 2019

相关概念视频

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.